Is NRILY a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Financial IT and shared platforms, with revenue (fy3/2026) at ~¥814.7B (+6.5%). The bear case rests on the most visible risk is that NRI's acquisitions abroad keep disappointing: the ~¥97 billion of FY3/2026 impairments at NRI Australia and Core BTS wiped out most of that year's reported profit, and the new targets of ~¥120 billion of overseas revenue at a ~5% margin still have to be delivered by businesses that shrank last year. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The most visible risk is that NRI's acquisitions abroad keep disappointing: the ~¥97 billion of FY3/2026 impairments at NRI Australia and Core BTS wiped out most of that year's reported profit, and the new targets of ~¥120 billion of overseas revenue at a ~5% margin still have to be delivered by businesses that shrank last year. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

Financial IT and shared platforms. Financial IT Solutions is where most of NRI's profit sits.

The most visible risk is that NRI's acquisitions abroad keep disappointing: the ~¥97 billion of FY3/2026 impairments at NRI Australia and Core BTS wiped out most of that year's reported profit, and the new targets of ~¥120 billion of overseas revenue at a ~5% margin still have to be delivered by businesses that shrank last year. At home, revenue is concentrated in Japanese financial institutions, so a slowdown in IT spending by brokers, banks or insurers, or consolidation among them, would hit the largest and most profitable segment; the company's own outlook warns that spending may be held back if client earnings weaken. Generative AI cuts both ways for a firm that bills for system development: NRI reports 10x to 30x productivity gains on some projects, which could lift margins but could also push clients to expect lower prices or to do more in-house. Competition for scarce engineers in Japan can also squeeze project margins. Public-sector work is lumpy, as the June 2026 quarter showed when slow public orders cut Consulting profit by 8.7%. Nomura Holdings' ~20% stake gives it influence and also means any future sell-down could weigh on the shares. For NRILY holders specifically, returns are exposed to the yen-dollar rate, the ADR is an unsponsored over-the-counter program with thinner trading and wider spreads than the Tokyo listing, and Japanese tax is withheld from dividends before they reach US holders. Finally, the ¥175 billion operating-profit forecast for FY3/2027 assumes growth continues while NRI steps up spending on AI, security and R&D (forecast at ¥8 billion, up 47.8%).

Tokyo-based consulting and IT services group that builds and runs systems, many of them shared platforms, mainly for Japanese financial institutions.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Financial IT and shared platforms) stalling in the reported numbers rather than in the narrative, the risk above (the most visible risk is that NRI's acquisitions abroad keep disappointing: the ~¥97 billion of FY3/2026 impairments at NRI Australia and Core BTS wiped out most of that year's reported profit, and the new targets of ~¥120 billion of overseas revenue at a ~5% margin still have to be delivered by businesses that shrank last year) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

NRILY is the ticker for American depositary receipts of Nomura Research Institute, Ltd., which trade over the counter in the US. According to Citibank, the depositary, each ADR represents one ordinary share of NRI, whose main listing is on the Tokyo Stock Exchange Prime Market under code 4307. The program is unsponsored, meaning Citibank set it up without a formal deposit agreement with NRI.

NRILY trades on the US over-the-counter market rather than on the NYSE or Nasdaq, so you need a brokerage account that allows OTC securities. Many large US brokers do, sometimes with extra fees or restrictions. Trading volume is usually far lower than in Tokyo, so bid-ask spreads can be wider, and some investors use limit orders for that reason.

Yes. NRI pays twice a year, with record dates of September 30 and March 31. It paid ¥77 per share for the fiscal year ended March 2026 (¥35 interim and ¥42 year-end) and forecasts ¥84 for the year ending March 2027. ADR holders receive the dividend in dollars after currency conversion, depositary fees and Japanese withholding tax.